A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100mg or 150 mg: II. The comparison of bleeding patterns: World health organization task force on long-acting systemic agents for fertility regulation special programme of research, development and research training in human reproduction